![Christopher Cabell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Cabell
President chez
INHIBIKASE THERAPEUTICS, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Christopher H.
Cabell is Chief Executive Officer at Corhepta Pharmaceuticals, Inc. since 2024.
Dr. Cabell is Director at ScienceMedia, Inc. since 2020.
Dr. Cabell is Independent Director at Pulmatrix, Inc. since 2020.
Dr. Cabell is a Member of the American College of Cardiology Foundation.
Dr. Cabell is President & Head-Research & Development at Inhibikase Therapeutics, Inc. starting 2025.
Formerly, Dr. Cabell was Chief Medical Officer & Executive Vice President at Zura Bio Ltd. from 2023 to 2024.
Dr. Cabell was Chief Medical Officer & Head-Clinical Development at Emergent BioSolutions, Inc. from 2021 to 2023.
Dr. Cabell was Chief Medical Officer, Head-Research & Development at Arena Pharmaceuticals, Inc. in 2020.
Dr. Cabell was Senior VP & Head-Therapeutic Delivery Unit at Quintiles Transnational Corp.
from 2015 to 2017.
Dr. Cabell was Chief Medical & Scientific Officer at Quintiles, Inc. (California) from 2007 to 2017.
Dr. Cabell was Chief Medical & Scientific Officer at IQVIA RDS, Inc. from 2007 to 2017.
Dr. Cabell was Chief Medical & Scientific Officer at IQVIA, Inc. Formerly, Dr. Cabell was Director at Cenduit LLC.
Dr. Cabell was Director-Echocardiography Core Lab at Duke Clinical Research Institute.
Dr. Cabell was Co-Chairman at Cardiac Safety Research Consortium.
Dr. Cabell was Co-Chairman at US Food & Drug Administration.
Dr. Cabell was Associate Professor at Duke University School of Medicine.
Education includes graduate degree from Duke University, undergraduate degree from The Pennsylvania State University, and doctorate from Duke University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 676 564 ( 0,51 % ) | 1 M $ | 31/05/2026 | |
PULMATRIX INC -.--% | 23/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Christopher Cabell
| Sociétés | Poste | Début |
|---|---|---|
| PULMATRIX, INC. | Directeur/Membre du Conseil | 23/06/2020 |
| INHIBIKASE THERAPEUTICS, INC. | President | 21/02/2025 |
ScienceMedia, Inc.
 ScienceMedia, Inc. Electronics DistributorsDistribution Services Engages in delivering technological and institutional innovation in scientific education | Directeur/Membre du Conseil | 18/02/2020 |
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Corporate Officer/Principal | 30/04/2009 |
Anciens postes connus de Christopher Cabell
| Sociétés | Poste | Fin |
|---|---|---|
| ZURA BIO LIMITED | Directeur Technique/Scientifique/R&D | 15/01/2024 |
| EMERGENT BIOSOLUTIONS INC. | Directeur Technique/Scientifique/R&D | 01/01/2023 |
| ARENA PHARMACEUTICALS | Directeur Technique/Scientifique/R&D | 01/12/2020 |
IQVIA RDS, Inc.
 IQVIA RDS, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical engineering and life sciences | Directeur Technique/Scientifique/R&D | 01/09/2017 |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development, marketing & public opinion polling services | Directeur Technique/Scientifique/R&D | 22/07/2011 |
Formation de Christopher Cabell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development, marketing & public opinion polling services | Commercial Services |
IQVIA, Inc.
 IQVIA, Inc. Packaged SoftwareTechnology Services Provides AI assistant, analytics and clinical research services for healthcare sector | Technology Services |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke Clinical Research Institute
 Duke Clinical Research Institute Pharmaceuticals: OtherHealth Technology Manufactures medical and botanical products | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Health Services |
IQVIA RDS, Inc.
IQVIA RDS, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical engineering and life sciences | Commercial Services |
Cenduit LLC
 Cenduit LLC Packaged SoftwareTechnology Services Provides clinical supply chain intelligence, operations management and technology services | Technology Services |
ScienceMedia, Inc.
ScienceMedia, Inc. Electronics DistributorsDistribution Services Engages in delivering technological and institutional innovation in scientific education | Distribution Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Cardiac Safety Research Consortium | |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
